glp 1 donald trump Doctors And GLP-1 Users Respond To Trump's 'Fat Drugs' Comments Trump Says He 'Probably Should'

Winners Alabama / Huntsville Gains a $6B high-tech pharma plant 450 long-term skilled jobs + 3,000 construction jobs Strengthens the regions biotech footprint Eli Lilly Expands U.S

Acknowledgements Work from the Queen Mary University of London laboratory is currently supported by the research into ageing fund, set up and managed by AgeUK, British Biotechnology Science Research Council, Dunhill Medical Trust, and Takeda Pharmaceuticals

One hot car trip

The FDA has announced the issuance of 30 warning letters to telehealth companies, targeting firms making false or misleading claims regarding compounded GLP-1 products, such as semaglutide and tirzepatide, offered on their digital platforms